Copenhagen, Denmark and Hradec Králové, Czechia – 20.04.2026 – RetinaLyze, a leader in AI-driven eye screening and tele-ophthalmology, today announced a strategic cooperation with OCULUS spol. s r.o. The vision is to make accessible, high-quality retinal screening available to more patients and providers across the Czech Republic.
Under the agreement, OCULUS spol. s r. o. will introduce and support RetinaLyze’s CE-marked AI screening and telemedicine services within optometry stores, eye clinics, occupational health providers, and primary care networks throughout the region. The collaboration combines RetinaLyze’s clinically validated decision support with OCULUS deep market presence and hands-on customer support.
“Czech customers are asking for screening solutions that are fast to deploy, clinically reliable, and easy for staff to use,” said Michal Vymyslicky, CEO of OCULUS spol. s r. o. “By partnering with RetinaLyze, we can deliver proven AI workflows and tele-ophthalmology services that help customers detect retinal disease earlier, streamline referrals, and elevate the standard of care.”
The cooperation will focus on:
Faster access to screening:
Same-day onboarding and cloud-based workflows designed for high-throughput retail and clinical environments.
Proven clinical performance: AI analysis for signs of common retinal diseases with tele-ophthalmology review to support accurate, timely decisions.
Operational simplicity: Vendor-agnostic compatibility with leading fundus cameras and straightforward EHR/reporting export options.
Scalable support: Local training, service, and continuous optimization delivered by Oculus spol’s team.
“OCULUS customer-centric approach and track record in the Czechia make them an ideal collaborator,” said Teddy Birch
Petersen, CEO of RetinaLyze. “Together we’re enabling more providers to adopt AI-supported screening that fits daily workflows and measurably improves patient pathways.”
For more information about RetinaLyze and its AI-powered eye screening solutions, visit https://retinalyze.com.
To learn more about OCULUS spol. s r. o, visit www.oculus.cz
Contact
Teddy Birch Petersen
CEO
RetinaLyze System A/S
tbp@retinalyze.com
Michal Vymyslicky
CEO
OCULUS spol. s r.o.
vymyslicky@oculus.cz
About RetinaLyze System A/S
RetinaLyze System A/S is a Denmark-based software company that provides artificial intelligence and telemedicine solutions for the optometry and healthcare industry. Its innovative software platform is designed to assist healthcare professionals in the early detection of eye diseases, enhancing patient outcomes through timely intervention.
OCULUS spol. s r.o. is an exclusive medical technology distributor of OCULUS and Nidek serving healthcare providers across the Czech Republic with consultative sales, training, and service with over 30 years of experience on the market.